A major step towards effective treatment evaluation in primary biliary cirrhosis

Journal of Hepatology

Volumn 55, Issue 6, 2011, Pages 1178-1180

  Beuers, Ulrich ^a   Lindor, Keith D ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BEZAFIBRATE; BUDESONIDE; FENOFIBRATE; OBETICHOLIC ACID; PLACEBO; URSODEOXYCHOLIC ACID;

ALKALINE PHOSPHATASE BLOOD LEVEL; CLINICAL TRIAL; DRUG EFFICACY; ENVIRONMENTAL FACTOR; HEREDITY; HUMAN; INFLAMMATION; LIFE EXPECTANCY; LIVER FIBROSIS; PORTAL HYPERTENSION; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; REVIEW; THERAPY EFFECT;

EID: 81355138630     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2011.04.012     Document Type: Editorial

References (20)

1. EASL Clinical Practice Guidelines: Management of cholestatic liver diseases. J Hepatol 2009;51:237-267.
2. K.D. Lindor, M.E. Gershwin, R. Poupon, M. Kaplan, N.V. Bergasa, and E.J. Heathcote Primary biliary cirrhosis Hepatology 50 2009 291 308
3. M.E. Gershwin, and I.R. Mackay The causes of primary biliary cirrhosis: convenient and inconvenient truths Hepatology 47 2008 737 745
4. S. Hohenester, R.P. Oude-Elferink, and U. Beuers Primary biliary cirrhosis Semin Immunopathol 31 2009 283 307
5. P. Invernizzi, and M.E. Gershwin The genetic basis of primary biliary cirrhosis: premises, not promises Gastroenterology 135 2008 1044 1047
6. G.M. Hirschfield, X. Liu, C. Xu, Y. Lu, G. Xie, and X. Gu Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants N Engl J Med 360 2009 2544 2555
7. C. Selmi, D.L. Balkwill, P. Invernizzi, A.A. Ansari, R.L. Coppel, and M. Podda Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium Hepatology 38 2003 1250 1257
8. M.E. Gershwin, C. Selmi, H.J. Worman, E.B. Gold, M. Watnik, and J. Utts Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients Hepatology 42 2005 1194 1202
9. A. Ala, C.M. Stanca, M. Bu-Ghanim, I. Ahmado, A.D. Branch, and T.D. Schiano Increased prevalence of primary biliary cirrhosis near superfund toxic waste sites Hepatology 43 2006 525 531
10. U. Beuers, S. Hohenester, L.J. de Buy Wenniger, A.E. Kremer, P.L. Jansen, and R.P. Elferink The biliary HCO(3)(-) umbrella: a unifying hypothesis on pathogenetic and therapeutic aspects of fibrosing cholangiopathies Hepatology 52 2010 1489 1496
11. J.F. Medina, A. Martinez, J.J. Vazquez, and J. Prieto Decreased anion exchanger 2 immunoreactivity in the liver of patients with primary biliary cirrhosis Hepatology 25 1997 12 17
12. U. Beuers Drug insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis Nat Clin Pract Gastroenterol Hepatol 3 2006 318 328
13. A. Pares, L. Caballeria, and J. Rodes Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid Gastroenterology 130 2006 715 720
14. C. Corpechot, L. Abenavoli, N. Rabahi, Y. Chretien, T. Andreani, and C. Johanet Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis Hepatology 48 2008 871 877
15. E.M. Kuiper, B.E. Hansen, R.A. de Vries, J.W. den Ouden-Muller, T.J. van Ditzhuijsen, and E.B. Haagsma Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid Gastroenterology 136 2009 1281 1287
16. M.G. Silveira, E.M. Brunt, J. Heathcote, G.J. Gores, K.D. Lindor, and M.J. Mayo American Association for the Study of Liver Diseases endpoints conference: design and endpoints for clinical trials in primary biliary cirrhosis Hepatology 52 2010 349 359
17. J.M. Shapiro, H. Smith, and F. Schaffner Serum bilirubin: a prognostic factor in primary biliary cirrhosis Gut 20 1979 137 140
18. E.R. Dickson, P.M. Grambsch, T.R. Fleming, L.D. Fisher, and A. Langworthy Prognosis in primary biliary cirrhosis: model for decision making Hepatology 10 1989 1 7
19. T. Kumagi, M. Guindi, S.E. Fischer, T. Arenovich, R. Abdalian, and C. Coltescu Baseline ductopenia and treatment response predict long-term histological progression in primary biliary cirrhosis Am J Gastroenterol 105 2010 2186 2194
20. C. Corpechot, O. Chazouilleres, and R. Poupon Early primary biliary cirrhosis: biochemical response to treatment and prediction of long-term outcome J Hepatol 55 2011 1361 1367